Compounds > 4-7-10-13-16-19-docosahexaenoic-acid-dopamine-conjugate

4-7-10-13-16-19-docosahexaenoic-acid-dopamine-conjugate and Parkinsonian-Disorders

4-7-10-13-16-19-docosahexaenoic-acid-dopamine-conjugate has been researched along with Parkinsonian-Disorders* in 1 studies

Other Studies

1 other study(ies) available for 4-7-10-13-16-19-docosahexaenoic-acid-dopamine-conjugate and Parkinsonian-Disorders

Article	Year
Antioxidant and neuroprotective properties of N-docosahexaenoyl dopamine. Bulletin of experimental biology and medicine, 2006, Volume: 142, Issue:4 N-Docosahexaenoyl dopamine exhibited antioxidant activity in the test with a stable oxygen radical galvinoxyl. This compound produced a dose-dependent protective effect on cultured granular cells from rat cerebellum under conditions of oxidative stress. N-Docosahexaenoyl dopamine decelerated the development of symptoms of Parkinson's disease in mice receiving neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Topics: Animals; Antioxidants; Cells, Cultured; Cerebellum; Dopamine; Dose-Response Relationship, Drug; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Rats	2006

Article

Year

Antioxidant and neuroprotective properties of N-docosahexaenoyl dopamine.

Bulletin of experimental biology and medicine, 2006, Volume: 142, Issue:4

N-Docosahexaenoyl dopamine exhibited antioxidant activity in the test with a stable oxygen radical galvinoxyl. This compound produced a dose-dependent protective effect on cultured granular cells from rat cerebellum under conditions of oxidative stress. N-Docosahexaenoyl dopamine decelerated the development of symptoms of Parkinson's disease in mice receiving neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Topics: Animals; Antioxidants; Cells, Cultured; Cerebellum; Dopamine; Dose-Response Relationship, Drug; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Rats

2006